TMS (MagVenture MagPro 100 with MagOption)
TMS (MagVenture MagPro 100 with MagOption) is a medical device with 3 clinical trials. Currently 1 active trials ongoing.
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
2 source entries across 2 studies. This list may not include all unresolved or historical entries.
- TMS (MagVenture MagPro 100 with MagOption)Registry intervention
Linked study entry; product equivalence not established
View study and source - TMS (MagVenture MagPro 100 with MagOption)Registry intervention
Linked study entry; product equivalence not established
View study and source
Success Metrics
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
0.0%
0 of 0 finished
0.0%
0 ended early
1
trials recruiting
3
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder
Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)
Mechanism of Non-invasive Magnetic Stimulation
Clinical Trials (3)
Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder
Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)
Mechanism of Non-invasive Magnetic Stimulation
All 3 trials loaded
Drug Details
- Intervention Type
- Device
- Total Trials
- 3